Literature DB >> 7918315

Hyperinsulinemia, risk factors, and coronary heart disease. The Zutphen Elderly Study.

E J Feskens1, D Kromhout.   

Abstract

We investigated the association between fasting insulin concentration--an indicator of insulin resistance in nondiabetic individuals--cardiovascular risk factors, and coronary heart disease in a study of 390 men in the town of Zutphen. In 1990, an extensive examination was carried out on the participating men (aged 70 to 89 years). Fasting insulin levels were determined and a number of other risk factors measured. Known and newly diagnosed diabetics were excluded from the data analyses. Fasting insulin concentration was significantly associated with levels of glucose, triglycerides, uric acid, serum albumin, creatinine, and fibrinogen as well as resting heart rate. Inverse associations with high-density lipoprotein cholesterol and factor VII activity were observed. These results were independent of confounding factors such as age, body mass index, ratio of subscapular to triceps skinfold thicknesses, cigarette smoking, physical activity, and alcohol consumption. Men with a fasting insulin level higher than 80 pmol/L (highest quartile of the distribution) had a significantly higher prevalence of coronary heart disease and especially of myocardial infarction. This result was independent of potential confounding variables as well as of possible intermediates (total and high-density lipoprotein cholesterol, hypertension, serum triglycerides, fasting glucose, and other risk factors related to fasting insulin) (odds ratio, 2.2; 95% confidence interval, 1.2-4.0). No association between fasting insulin level and hypertension or blood pressure was observed. These results show that fasting insulin is an important indicator of coronary heart disease in elderly men. Clotting factors, resting heart rate, uric acid, serum albumin, and creatinine may also play a role in this metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7918315     DOI: 10.1161/01.atv.14.10.1641

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  7 in total

1.  Aging, metabolic syndrome and the heart.

Authors:  Guarner Veronica; Rubio-Ruiz Maria Esther
Journal:  Aging Dis       Date:  2012-03-13       Impact factor: 6.745

Review 2.  Assessment of serum albumin concentration as a risk factor for stroke and coronary disease in African Americans and whites.

Authors:  R F Gillum
Journal:  J Natl Med Assoc       Date:  2000-01       Impact factor: 1.798

3.  Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group.

Authors: 
Journal:  BMJ       Date:  1998-08-08

4.  Worksite health screening programs for predicting the development of Metabolic Syndrome in middle-aged employees: a five-year follow-up study.

Authors:  Yu-Cheng Lin; Jong-Dar Chen; Su-Huey Lo; Pau-Chung Chen
Journal:  BMC Public Health       Date:  2010-12-02       Impact factor: 3.295

5.  The cutoff values of indirect indices for measuring insulin resistance for metabolic syndrome in Korean children and adolescents.

Authors:  Jun Woo Kim; Sang Hoo Park; Yoojin Kim; Minji Im; Heon-Seok Han
Journal:  Ann Pediatr Endocrinol Metab       Date:  2016-09-30

6.  Stability of dietary patterns assessed with reduced rank regression; the Zutphen Elderly Study.

Authors:  Nicole Jankovic; Martinette T Steppel; Ellen Kampman; Lisette Cpgm de Groot; Hendriek C Boshuizen; Sabita S Soedamah-Muthu; Daan Kromhout; Edith Jm Feskens
Journal:  Nutr J       Date:  2014-04-01       Impact factor: 3.271

7.  Resting heart rate and impaired glucose regulation in middle-aged and elderly Chinese people: a cross-sectional analysis.

Authors:  Zhen Yang; Weiwei Zhang; Lingfei Zhu; Ning Lin; Yixin Niu; Xiaoyong Li; Shuai Lu; Hongmei Zhang; Xuanchun Wang; Jie Wen; Guang Ning; Li Qin; Qing Su
Journal:  BMC Cardiovasc Disord       Date:  2017-09-13       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.